'Standalone net sales (including other operating income) of Amrutanjan Health Care for the quarter ended Mar 2024 has increased 26.65% to Rs 127.06 crore. Operating profit margin has declined from 12.95% to 12.78%, leading to 25.02% rise in operating profit to Rs 16.24 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 22.47% to 23.48%. Purchase of finished goods cost fell from 27.45% to 25.17%. Employee cost decreased from 12.59% to 10.10%. Other expenses rose from 24.29% to 28.08%. Selling and administration expenses rose from 7.26% to 12.32%. Other income up 2.70% to Rs 4.95 crore. PBIDT rose 18.98% to Rs 21.19 crore. Provision for interest up 150% to Rs 0.05 crore. PBDT rose 18.83% to Rs 21.14 crore. Provision for depreciation rose 16.79% to Rs 1.53 crore. Profit before tax grew 18.99% to Rs 19.61 crore. Provision for t...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|